Pink Viagra
The FDA has approved Addyi (flibanserin), the first drug to treat low libido in premenopausal women who are diagnosed with hypoactive sexual desire disorder (HSDD), otherwise known as low sex drive. According to the FDA press release, the drug is being approved with a risk evaluation and mitigation strategy (REMS),…
Advocacy group cites connection between experimental drug flibanserin and world’s first synthetic estrogen, cause of DES Tragedy NEW YORK CITY, NY, June 15, 2015 – Suzanne Robotti, a DES Daughter and the Executive Director for DES Action USA, a nonprofit that advocates for DES-exposed individuals, is available to discuss concerns…
By Kari Christianson Program Director, DES Action USA Pink Viagra – Really?! The Food and Drug Administration has been seeking input from women about the condition “Female Sexual Dysfunction.” This is a fairly new term for low libido in women and has not been recognized by the American Psychiatric Association….
